glisoxepide

This page covers all glisoxepide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sulfonylurea receptor 1, Kir6.2.

Targets

Sulfonylurea receptor 1, Kir6.2

Phase 2 pipeline (1)

• Glisepin · Metabolic
  Glisoxepide works by blocking potassium channels in the pancreas, allowing more insulin to be released.

Patent intelligence

• glisoxepide patent landscape — aggregated cliff calendar, attackable patents, originator estates